株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

免疫グロブリンE (IgE) アレルギー血液検査:医療機器のパイプライン評価

IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016

発行 GlobalData 商品コード 356280
出版日 ページ情報 英文 41 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.53円で換算しております。
Back to Top
免疫グロブリンE (IgE) アレルギー血液検査:医療機器のパイプライン評価 IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016
出版日: 2016年03月11日 ページ情報: 英文 41 Pages
概要

当レポートでは、世界の免疫グロブリンE (IgE) アレルギー血液検査の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (ライセンス契約・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 免疫グロブリンE (IgE) アレルギー血液検査の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別

第4章 治験中のパイプライン製品:企業別

  • IgEアレルギー血液検査装置の企業:治験段階別のパイプライン製品
  • IgEアレルギー血液検査装置:治験段階別のパイプライン製品

第5章 IgEアレルギー血液検査装置市場:企業・製品の概要

  • Abionic SA
    • パイプライン製品および進行中の治験の概要
  • Amerimmune
  • Atomo Diagnostics Pty Limited
  • AXO Science S.A.S.
  • Biovator AB
  • Children's Hospital Boston
  • China Medical Technologies, Inc.
  • Cytognos, S.L.
  • HOB Biotech Group Co., Ltd.
  • Hycor Biomedical Inc.
  • Institut fur Produktqualitat GmbH
  • The Binding Site Group Ltd.
  • The University of Queensland
  • University of Connecticut Health Center
  • University of Nottingham
  • VEGA Ltd

第6章 IgEアレルギー血液検査市場:昨今の動向

第7章 付録

図表一覧

目次
Product Code: GDME0151EPD

GlobalData's Medical Devices sector report, "IgE Allergy Blood Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of IgE Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key IgE Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the IgE Allergy Blood Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of IgE Allergy Blood Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of IgE Allergy Blood Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. IgE Allergy Blood Tests Overview

3. Products under Development

  • 3.1. IgE Allergy Blood Tests - Pipeline Products by Stage of Development
  • 3.2. IgE Allergy Blood Tests - Pipeline Products by Territory
  • 3.3. IgE Allergy Blood Tests - Pipeline Products by Regulatory Path
  • 3.4. IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date

4. IgE Allergy Blood Tests - Pipeline Products under Development by Companies

  • 4.1. IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development
  • 4.2. IgE Allergy Blood Tests - Pipeline Products by Stage of Development

5. IgE Allergy Blood Tests Companies and Product Overview

  • 5.1. Abionic SA Company Overview
    • 5.1.1. Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Amerimmune Company Overview
    • 5.2.1. Amerimmune Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Atomo Diagnostics Pty Limited Company Overview
    • 5.3.1. Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. AXO Science S.A.S. Company Overview
    • 5.4.1. AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Biovator AB Company Overview
    • 5.5.1. Biovator AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Children's Hospital Boston Company Overview
    • 5.6.1. Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. China Medical Technologies, Inc. Company Overview
    • 5.7.1. China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Cytognos, S.L. Company Overview
    • 5.8.1. Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. HOB Biotech Group Co., Ltd. Company Overview
    • 5.9.1. HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Hycor Biomedical Inc. Company Overview
    • 5.10.1. Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Institut fur Produktqualitat GmbH Company Overview
    • 5.11.1. Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. The Binding Site Group Ltd. Company Overview
    • 5.12.1. The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. The University of Queensland Company Overview
    • 5.13.1. The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. University of Connecticut Health Center Company Overview
    • 5.14.1. University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. University of Nottingham Company Overview
    • 5.15.1. University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. VEGA Ltd Company Overview
    • 5.16.1. VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview

6. IgE Allergy Blood Tests- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: IgE Allergy Blood Tests - Pipeline Products by Stage of Development
  • Table 2: IgE Allergy Blood Tests - Pipeline Products by Territory
  • Table 3: IgE Allergy Blood Tests - Pipeline Products by Regulatory Path
  • Table 4: IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date
  • Table 5: IgE Allergy Blood Tests Companies - Pipeline Products by Stage of Development
  • Table 6: IgE Allergy Blood Tests - Pipeline Products by Stage of Development
  • Table 7: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: abioKIT - Product Status
  • Table 9: abioKIT - Product Description
  • Table 10: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Basophile Panel - Product Status
  • Table 12: Basophile Panel - Product Description
  • Table 13: CD69 and IgE Receptor Expression Assay - Product Status
  • Table 14: CD69 and IgE Receptor Expression Assay - Product Description
  • Table 15: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: AtomoRapid - Allergy - Product Status
  • Table 17: AtomoRapid - Allergy - Product Description
  • Table 18: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Companion Diagnostic Test - Allergy - Product Status
  • Table 20: Companion Diagnostic Test - Allergy - Product Description
  • Table 21: Diagnostic Test - Allergy - Product Status
  • Table 22: Diagnostic Test - Allergy - Product Description
  • Table 23: Biovator AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Cytokine Profile Assay - Product Status
  • Table 25: Cytokine Profile Assay - Product Description
  • Table 26: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Biomarker Assay - Allergy - Product Status
  • Table 28: Biomarker Assay - Allergy - Product Description
  • Table 29: China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Diagnostic Assay - Total IgE - Product Status
  • Table 31: Diagnostic Assay - Total IgE - Product Description
  • Table 32: Cytognos, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Status
  • Table 34: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Description
  • Table 35: HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: HOB Biotech Diagnostic Assay - Allergy - Product Status
  • Table 37: HOB Biotech Diagnostic Assay - Allergy - Product Description
  • Table 38: Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Status
  • Table 40: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Description
  • Table 41: HYTEC 288 PLUS - Tryptase Test - Product Status
  • Table 42: HYTEC 288 PLUS - Tryptase Test - Product Description
  • Table 43: Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Diagnostic Test - Allergy - Product Status
  • Table 45: Diagnostic Test - Allergy - Product Description
  • Table 46: The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: SPAplus - Immunoglobulin E Assay - Product Status
  • Table 48: SPAplus - Immunoglobulin E Assay - Product Description
  • Table 49: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Diagnostic Assay - Allergy - Product Status
  • Table 51: Diagnostic Assay - Allergy - Product Description
  • Table 52: University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Ultrasensitive Peanut Allergy Test - Product Status
  • Table 54: Ultrasensitive Peanut Allergy Test - Product Description
  • Table 55: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Allergy Test - Product Status
  • Table 57: Allergy Test - Product Description
  • Table 58: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Microarray Based Allergen Diagnostic Kit - Product Status
  • Table 60: Microarray Based Allergen Diagnostic Kit - Product Description
  • Table 61: Glossary

List of Figures

  • Figure 1: IgE Allergy Blood Tests - Pipeline Products by Stage of Development
  • Figure 2: IgE Allergy Blood Tests - Pipeline Products by Territory
  • Figure 3: IgE Allergy Blood Tests - Pipeline Products by Regulatory Path
  • Figure 4: IgE Allergy Blood Tests - Pipeline Products by Estimated Approval Date
Back to Top